
Kendra D. Carter
Examiner (ID: 7816)
| Most Active Art Unit | 1627 |
| Art Unit(s) | 1648, 1627, 1617, 3785 |
| Total Applications | 954 |
| Issued Applications | 357 |
| Pending Applications | 39 |
| Abandoned Applications | 556 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10241506
[patent_doc_number] => 20150126501
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-07
[patent_title] => 'Fused Ring Compound For Use As Mineralocorticoid Receptor Antagonist'
[patent_app_type] => utility
[patent_app_number] => 14/591081
[patent_app_country] => US
[patent_app_date] => 2015-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20376
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14591081
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/591081 | Fused ring compound for use as mineralocorticoid receptor antagonist | Jan 6, 2015 | Issued |
Array
(
[id] => 10367015
[patent_doc_number] => 20150252020
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-10
[patent_title] => 'Intramolecular Hydrogen-Bonded Nitric Oxide Synthase Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 14/589690
[patent_app_country] => US
[patent_app_date] => 2015-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7128
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14589690
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/589690 | Intramolecular hydrogen-bonded nitric oxide synthase inhibitors | Jan 4, 2015 | Issued |
Array
(
[id] => 10367015
[patent_doc_number] => 20150252020
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-10
[patent_title] => 'Intramolecular Hydrogen-Bonded Nitric Oxide Synthase Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 14/589690
[patent_app_country] => US
[patent_app_date] => 2015-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7128
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14589690
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/589690 | Intramolecular hydrogen-bonded nitric oxide synthase inhibitors | Jan 4, 2015 | Issued |
Array
(
[id] => 11270454
[patent_doc_number] => 20160333002
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-17
[patent_title] => 'N, N\' SUBSTITUTED PIPERIDINAMINE COMPOUNDS, AND PREPARATION METHOD AND USAGE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/105702
[patent_app_country] => US
[patent_app_date] => 2014-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 31593
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15105702
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/105702 | N,N' substituted piperidinamine compounds, and preparation method and usage thereof | Dec 18, 2014 | Issued |
Array
(
[id] => 11121954
[patent_doc_number] => 20160318929
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-03
[patent_title] => 'PYRAZOLO[1,5-A]PYRIDINE DERIVATIVES AND METHODS OF THEIR USE'
[patent_app_type] => utility
[patent_app_number] => 15/108400
[patent_app_country] => US
[patent_app_date] => 2014-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48291
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15108400
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/108400 | Pyrazolo[1,5-a]pyridine derivatives and methods of their use | Dec 17, 2014 | Issued |
Array
(
[id] => 13034345
[patent_doc_number] => 10039282
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-08-07
[patent_title] => Six-membered C--N-bonded aryl sulphide and aryl sulphoxide derivatives as pesticides
[patent_app_type] => utility
[patent_app_number] => 15/104004
[patent_app_country] => US
[patent_app_date] => 2014-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31745
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 256
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15104004
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/104004 | Six-membered C--N-bonded aryl sulphide and aryl sulphoxide derivatives as pesticides | Dec 11, 2014 | Issued |
Array
(
[id] => 11729283
[patent_doc_number] => 20170190726
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2017-07-06
[patent_title] => 'PRODRUG FOR RELEASE OF CISPLATIN AND CYCLOOXYGENASE INHIBITOR'
[patent_app_type] => utility
[patent_app_number] => 15/102700
[patent_app_country] => US
[patent_app_date] => 2014-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 12882
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15102700
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/102700 | PRODRUG FOR RELEASE OF CISPLATIN AND CYCLOOXYGENASE INHIBITOR | Dec 11, 2014 | Abandoned |
Array
(
[id] => 11729283
[patent_doc_number] => 20170190726
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2017-07-06
[patent_title] => 'PRODRUG FOR RELEASE OF CISPLATIN AND CYCLOOXYGENASE INHIBITOR'
[patent_app_type] => utility
[patent_app_number] => 15/102700
[patent_app_country] => US
[patent_app_date] => 2014-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 12882
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15102700
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/102700 | PRODRUG FOR RELEASE OF CISPLATIN AND CYCLOOXYGENASE INHIBITOR | Dec 11, 2014 | Abandoned |
Array
(
[id] => 11289111
[patent_doc_number] => 20160339043
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-24
[patent_title] => 'COMPOSITIONS AND METHODS FOR REDUCING INTRAOCULAR PRESSURE'
[patent_app_type] => utility
[patent_app_number] => 15/102201
[patent_app_country] => US
[patent_app_date] => 2014-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 11329
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15102201
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/102201 | Compositions and methods for reducing intraocular pressure | Dec 3, 2014 | Issued |
Array
(
[id] => 11698770
[patent_doc_number] => 09688674
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-06-27
[patent_title] => 'Selective EP4 receptor antagonistic substance for treatment of cancer'
[patent_app_type] => utility
[patent_app_number] => 14/547247
[patent_app_country] => US
[patent_app_date] => 2014-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 19628
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14547247
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/547247 | Selective EP4 receptor antagonistic substance for treatment of cancer | Nov 18, 2014 | Issued |
Array
(
[id] => 11612533
[patent_doc_number] => 09650383
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-16
[patent_title] => 'Aldose reductase inhibitors and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 14/541365
[patent_app_country] => US
[patent_app_date] => 2014-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 14940
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14541365
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/541365 | Aldose reductase inhibitors and uses thereof | Nov 13, 2014 | Issued |
Array
(
[id] => 11075631
[patent_doc_number] => 20160272596
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-22
[patent_title] => 'TETRAHYDRO-BENZODIAZEPINONES'
[patent_app_type] => utility
[patent_app_number] => 15/037240
[patent_app_country] => US
[patent_app_date] => 2014-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 78707
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15037240
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/037240 | Tetrahydro-benzodiazepinones | Nov 13, 2014 | Issued |
Array
(
[id] => 11067594
[patent_doc_number] => 20160264558
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-15
[patent_title] => 'FLUOROGENIC PROTECTING GROUP'
[patent_app_type] => utility
[patent_app_number] => 15/036302
[patent_app_country] => US
[patent_app_date] => 2014-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 9434
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15036302
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/036302 | FLUOROGENIC PROTECTING GROUP | Nov 12, 2014 | Abandoned |
Array
(
[id] => 11075632
[patent_doc_number] => 20160272595
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-22
[patent_title] => 'QUINAZOLINONE AND ISOQUINOLINONE DERIVATIVE'
[patent_app_type] => utility
[patent_app_number] => 15/030804
[patent_app_country] => US
[patent_app_date] => 2014-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 73821
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15030804
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/030804 | Quinazolinone and isoquinolinone derivative | Oct 22, 2014 | Issued |
Array
(
[id] => 9839693
[patent_doc_number] => 20150031775
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-29
[patent_title] => 'COMPOSITION AND METHOD FOR AFFECTING MALE AND FEMALE HORMONE LEVELS'
[patent_app_type] => utility
[patent_app_number] => 14/511844
[patent_app_country] => US
[patent_app_date] => 2014-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10324
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14511844
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/511844 | COMPOSITION AND METHOD FOR AFFECTING MALE AND FEMALE HORMONE LEVELS | Oct 9, 2014 | Abandoned |
Array
(
[id] => 9806609
[patent_doc_number] => 20150018551
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-15
[patent_title] => 'CYCLOALKANE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 14/502708
[patent_app_country] => US
[patent_app_date] => 2014-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 125422
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14502708
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/502708 | Cycloalkane derivatives | Sep 29, 2014 | Issued |
Array
(
[id] => 9806481
[patent_doc_number] => 20150018426
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-15
[patent_title] => 'Use of Tapentadol for Inhibiting and/or Treating Depression and Anxiety'
[patent_app_type] => utility
[patent_app_number] => 14/502552
[patent_app_country] => US
[patent_app_date] => 2014-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11788
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14502552
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/502552 | Use of Tapentadol for Inhibiting and/or Treating Depression and Anxiety | Sep 29, 2014 | Abandoned |
Array
(
[id] => 11243610
[patent_doc_number] => 09469643
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-10-18
[patent_title] => 'Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one'
[patent_app_type] => utility
[patent_app_number] => 14/493261
[patent_app_country] => US
[patent_app_date] => 2014-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 21
[patent_no_of_words] => 20136
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14493261
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/493261 | Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one | Sep 21, 2014 | Issued |
Array
(
[id] => 11009650
[patent_doc_number] => 20160206603
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-21
[patent_title] => 'COMPOSITION COMPRISING TORASEMIDE AND BACLOFEN FOR TREATING NEUROLOGICAL DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 14/914666
[patent_app_country] => US
[patent_app_date] => 2014-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 22952
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14914666
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/914666 | Composition comprising torasemide and baclofen for treating neurological disorders | Aug 31, 2014 | Issued |
Array
(
[id] => 11010931
[patent_doc_number] => 20160207883
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-21
[patent_title] => 'NOVEL AROMATIC COMPOUND AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/914941
[patent_app_country] => US
[patent_app_date] => 2014-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53655
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14914941
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/914941 | Aromatic compound and use thereof | Aug 28, 2014 | Issued |